Danaher gets conditional South Korean regulatory nod for $21 billion GE biopharma unit deal

SEOUL (Reuters) - South Korea's antitrust watchdog has approved Danaher Corp's proposed $21.4 billion (£16.5 billion)acquisition of General Electric's biopharma division on condition that they sell certain assets to address monopoly concerns.The U.S. medical equipment maker Danaher got conditional EU approval in December for the deal after agreeing to sell five businesses to address worries about competition.GE agreed a year ago to sell its biopharma business to Danaher in the biggest..